This course, worth 1.5 CME credits, covers the thromboprophylaxis and latest treatment recommendations for cancer-associated thrombosis via clinical scenarios that are likely to be encountered in primary care. It is authored by Consultant Medical Oncologist Dr Omar Khan.
Go at your own pace and download your CME certificate on completion
What you'll learn
- The extent of the disease burden of VTE in cancer patients
- Aetiology and clinical risk factors
- Patient groups in which VTE thromboprophylaxis is indicated
- Thromboprophylaxis in patients on long-term tamoxifen
- Key evidence-based considerations when prescribing DOACs and LMWH
- Optimum duration for treatment of cancer-associated VTE
- How to manage incidental or clinically unsuspected VTE
- How to manage recurrent VTE despite anticoagulation